Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women
Effects of Pregnancy on the Physico-chemical Characteristics of Cerebrospinal Acid-base Equilibrium
1 other identifier
observational
40
1 country
1
Brief Summary
The third trimester of pregnancy is typically characterized by the development of a marked respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still unknown. Aim of this study is to characterize, according to Stewart's approach, the acid-base equilibrium of CSF and arterial plasma of pregnant women and compare the results with data obtained from fertile, non-pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2018
CompletedFirst Posted
Study publicly available on registry
April 12, 2018
CompletedStudy Start
First participant enrolled
April 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedApril 17, 2018
April 1, 2018
12 months
March 29, 2018
April 16, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Strong Ion Difference
Strong Ion Difference (expressed in milliequivalents per Liter \[mEq/L\]) of cerebrospinal fluid and arterial plasma
1 day
Secondary Outcomes (6)
Partial pressure of carbon dioxide (PCO2)
1 day
Sum of albumin (expressed in mmol/L) and Phosphates (expressed in mmol/L)
1 day
Difference between cerebrospinal fluid and arterial plasma Strong Ion Difference (Delta SID)
1 day
Difference between cerebrospinal fluid and arterial plasma partial pressure of CO2 (Delta PCO2)
1 day
Progesterone levels
1 day
- +1 more secondary outcomes
Other Outcomes (4)
SID PCO2 correlation
1 day
Osmolality PCO2 correlation
1 day
Plasma progesterone PCO2 correlation
1 day
- +1 more other outcomes
Study Arms (2)
Pregnant Women
Pregnant women with gestational age \> 35 weeks undergoing spinal anesthesia for elective cesarean section.
Control Group
Fertile, non-pregnant women undergoing spinal anesthesia for elective surgery.
Interventions
Samples of cerebrospinal fluid and arterial blood will be collected anaerobically to measure acid-base variables, electrolytes, albumin, progesterone and copeptin levels
Eligibility Criteria
Women undergoing spinal anesthesia either for elective cesarean section of for elective surgery.
You may qualify if:
- Pregnancy with gestational age \> 35 weeks
- Scheduled elective cesarean section under spinal anesthesia
You may not qualify if:
- known respiratory or neurologic disease
- multiple pregnancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Related Publications (1)
Zadek F, Giudici G, Ferraris Fusarini C, Ambrosini MT, di Modugno A, Scaravilli V, Zanella A, Fumagalli R, Stocchetti N, Calderini E, Langer T. Cerebrospinal fluid and arterial acid-base equilibria in spontaneously breathing third-trimester pregnant women. Br J Anaesth. 2022 Nov;129(5):726-733. doi: 10.1016/j.bja.2022.07.048. Epub 2022 Sep 10.
PMID: 36096944DERIVED
Biospecimen
samples of plasma and cerebrospinal fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Langer, MD
University of Milan
- STUDY DIRECTOR
Antonio Pesenti, MD
University of Milan
- STUDY CHAIR
Edoardo Calderini, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano
- STUDY CHAIR
Giorgio Giudici, MD
University of Milan
- STUDY CHAIR
Mariateresa Ambrosini, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico di Milano
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2018
First Posted
April 12, 2018
Study Start
April 13, 2018
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
April 17, 2018
Record last verified: 2018-04